CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. - Edinger,M.; Hoffmann,P.; Ermann,J.; Drago,K.; Fathman,CG.; Strober,S.; Negrin,RS. (Nat Med, 2003)